. 2011 Feb 15;6:17–26. doi: 10.4137/BMI.S6487

Table 3.

Comparison of FXYD3 mRNA with other mRNAs identified as potential biomarkers for urothelial carcinoma of the renal pelvis.

	Fold changes to normal			Significant cases¹	UC vs. normal²	Significance³	UC vs. RCC²	Significance³
	Mean	Min	Max	Significant cases¹	UC vs. normal²	Significance³	UC vs. RCC²	Significance³
FXYD3	10.5	1.07	30.4	13/14 (93%)	0.00062	***	0.00058	***
p63	4.81	1.37	13.3	12/14 (86%)	0.0036	**	0.0034	**
KRT20	37	–1.36	181	7/14 (50%)	0.046	*	0.046	*
KRT7	11.2	–4.92	28.4	10/14 (71%)	0.00088	***	0.00048	***
S100P	107	3.9	275	12/14 (85.7%)	0.0011	**	0.0011	**
Vimentin	–3.61	–10.2	2.07	0/14 (0%)	0.032	*	<0.0001	***

Notes:

Significant cases were defined to be at least 3 SDs away from normal mean expressions;

P-values were obtained using two tailed student t-test;

Significance codes: 0–0.001 = ***, 0.001–0.01 = **, 0.01–0.05 = *, 0.05–0.1 = ., 0.1–1 = “ ”.